chrX-85270872-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_001330574.2(ZNF711):āc.1468A>Cā(p.Lys490Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000166 in 1,207,762 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., 1 hem., cov: 23)
Exomes š: 0.000016 ( 0 hom. 5 hem. )
Consequence
ZNF711
NM_001330574.2 missense
NM_001330574.2 missense
Scores
8
9
Clinical Significance
Conservation
PhyloP100: 6.73
Genes affected
ZNF711 (HGNC:13128): (zinc finger protein 711) This gene encodes a zinc finger protein of unknown function. It bears similarity to a zinc finger protein which acts as a transcriptional activator. This gene lies in a region of the X chromosome which has been associated with cognitive disability. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.083151996).
BP6
Variant X-85270872-A-C is Benign according to our data. Variant chrX-85270872-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 521141.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF711 | NM_001330574.2 | c.1468A>C | p.Lys490Gln | missense_variant | 11/11 | ENST00000674551.1 | NP_001317503.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF711 | ENST00000674551.1 | c.1468A>C | p.Lys490Gln | missense_variant | 11/11 | NM_001330574.2 | ENSP00000502839.1 | |||
ZNF711 | ENST00000360700.4 | c.1468A>C | p.Lys490Gln | missense_variant | 10/10 | 1 | ENSP00000353922.4 | |||
ZNF711 | ENST00000276123.7 | c.1330A>C | p.Lys444Gln | missense_variant | 10/10 | 1 | ENSP00000276123.3 | |||
ZNF711 | ENST00000373165.7 | c.1330A>C | p.Lys444Gln | missense_variant | 9/9 | 1 | ENSP00000362260.3 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 111920Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34126
GnomAD3 genomes
AF:
AC:
3
AN:
111920
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34126
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000905 AC: 16AN: 176875Hom.: 0 AF XY: 0.0000804 AC XY: 5AN XY: 62213
GnomAD3 exomes
AF:
AC:
16
AN:
176875
Hom.:
AF XY:
AC XY:
5
AN XY:
62213
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000155 AC: 17AN: 1095842Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 361684
GnomAD4 exome
AF:
AC:
17
AN:
1095842
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
361684
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000268 AC: 3AN: 111920Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34126
GnomAD4 genome
AF:
AC:
3
AN:
111920
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34126
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
10
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 09, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
P;P;D
Vest4
MutPred
Loss of methylation at K444 (P = 9e-04);Loss of methylation at K444 (P = 9e-04);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at